Rivanna Medical
  • Products
    • ProductsAccuro
    • Consumables
  • Resources
    • TrainingTraining
    • Testimonials
    • Clinical Value
    • Articles & Press
    • Upgrade
  • About
    • AboutRIVANNA
    • Leadership & BOD
    • Careers
  • Contact
    • ContactContact Us
    • Return Policy
  • Get Quote
Select Page
How 63% Fewer Readmissions Start with Smarter Healthcare Efficiency and AI

How 63% Fewer Readmissions Start with Smarter Healthcare Efficiency and AI

by RIVANNA | Nov 10, 2025 | News

The healthcare environment in the US is one of constant change and fluidity. Changing demographic trends, economic forces, and advances in medical research and technology have significant impacts on healthcare and hospital performance and operations. The modern...

RIVANNA awarded $3 million CDMRP grant to develop military-optimized ultrasound guidance system for spinal interventions

by RIVANNA | Oct 21, 2025 | Press Releases

CHARLOTTESVILLE, VA, OCTOBER 21, 2025 — RIVANNA®, developer of world-first imaging-based medical technologies, has recently been awarded with a Peer-Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award (TTDA) from the Congressionally...
10% Lower OR Costs: How Neuraxial Anesthesia Is Delivering Measurable Hospital Savings

10% Lower OR Costs: How Neuraxial Anesthesia Is Delivering Measurable Hospital Savings

by RIVANNA | Oct 15, 2025 | News

Healthcare economics have never been more challenging. Rising costs, flat reimbursements, and pressure for quality outcomes mean every clinical decision has a financial impact. At the same time, payers are stripping away traditional payment modifiers, making it harder...
What is Neuraxial Anesthesia? A Data-Driven Look at a Key Pillar in Modern Healthcare

What is Neuraxial Anesthesia? A Data-Driven Look at a Key Pillar in Modern Healthcare

by RIVANNA | Oct 7, 2025 | News

For hospital healthcare executives, navigating the complex landscape of clinical outcomes, patient satisfaction, and financial performance is a constant balancing act. Within this landscape, neuraxial anesthesia, which is a cornerstone of modern surgical and obstetric...

RIVANNA named a finalist in Medtech Innovator’s 2025 Early-Stage Grand Prize competition

by RIVANNA | Oct 2, 2025 | Press Releases

CHARLOTTESVILLE, VA, OCTOBER 2, 2025 — RIVANNA®, developer of world-first imaging-based medical technologies, today announced it has been named a finalist in MedTech Innovator’s (MTI) 2025 Early-Stage Grand Prize competition. The recognition comes as part of the...
« Older Entries
Next Entries »

Recent Posts

  • RIVANNA Crosses 100-patent Threshold: Estate Protects Shared Platform Spanning Multiple FDA-cleared Product Lines
  • RIVANNA Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance
  • The Inflection Point for Neuraxial Guidance
  • Using AI to Strengthen Clinical Confidence: RIVANNA’s Will Mauldin on the Outcomes Rocket Podcast
  • RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System

Products


Accuro
Accuro 3S
Accessories
Consumables
True-View Phantoms

Resources


Clinical Evidence
Testimonial
Accuro Academy
Articles & Press
True-View Phantoms

Resources


Product Documents
Service & Warranty
Software Updates
Contact Us

About

RIVANNA
Technology
Mission, Vision, & Values
Leadership, BOD, & Advisory
Careers

  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Instagram
Designed by ProvenContent.com © 2026 RIVANNA MEDICAL | 2400 HUNTERS WAY | CHARLOTTESVILLE, VA 22911